LILLO, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 471
EU - Europa 453
AS - Asia 118
AF - Africa 54
OC - Oceania 3
SA - Sud America 3
Totale 1.102
Nazione #
US - Stati Uniti d'America 466
IT - Italia 251
SE - Svezia 54
SG - Singapore 53
DE - Germania 45
GB - Regno Unito 36
CI - Costa d'Avorio 29
CN - Cina 25
FR - Francia 21
IN - India 18
BG - Bulgaria 14
CZ - Repubblica Ceca 13
SN - Senegal 13
NG - Nigeria 12
IR - Iran 10
ES - Italia 7
AU - Australia 3
CO - Colombia 3
HK - Hong Kong 3
MX - Messico 3
RO - Romania 3
TW - Taiwan 3
VN - Vietnam 3
CA - Canada 2
GR - Grecia 2
JP - Giappone 2
LU - Lussemburgo 2
AT - Austria 1
FI - Finlandia 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
UA - Ucraina 1
Totale 1.102
Città #
Milan 120
Chicago 94
Chandler 44
Ashburn 34
Florence 34
London 32
Singapore 30
Abidjan 29
Frankfurt am Main 27
New York 26
Woodbridge 24
Fairfield 23
Serra 17
Marseille 16
Rome 15
Wilmington 15
Sofia 14
Brno 13
Dakar 13
Ann Arbor 12
Lagos 12
Seattle 11
Bremen 10
Hyderabad 10
Pisa 10
Redwood City 10
Cambridge 9
Houston 8
Pune 7
Lawrence 6
Princeton 6
Beijing 5
Boardman 5
Dallas 5
Los Angeles 5
Newark 5
Ogden 5
Santa Clara 4
Villamartín 4
Buffalo 3
San Diego 3
Taipei 3
Central District 2
Dearborn 2
Dong Ket 2
Hesperange 2
Kent 2
Manchester 2
Medford 2
Munich 2
Norwalk 2
Palo Alto 2
Pontedera 2
Shenzhen 2
South Plainfield 2
Turin 2
Athens 1
Bangalore 1
Canberra 1
Caserta 1
Chattanooga 1
Des Moines 1
Genoa 1
Hangzhou 1
Karachi 1
Kasumicho 1
Kipfenberg 1
Kunming 1
Lahti 1
Lüneburg 1
Montaigu-de-Quercy 1
Mosina 1
Nanjing 1
New Haven 1
Ottawa 1
San Jose 1
San Venanzo 1
Sha Tin Wai 1
Sibiu 1
Slattum 1
Spinea 1
Tappahannock 1
Templestowe 1
Toronto 1
Trescore Cremasco 1
Vienna 1
Washington 1
Wenzhou 1
Wuhan 1
Xiaogan 1
Zhengzhou 1
Totale 841
Nome #
Modelling systemic price cojumps with Hawkes factor models 113
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 104
Why are learned indexes so effective? 103
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 91
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 86
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 86
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 84
$FAKE: Evidence of spam and bot activity in stock microblogs on twitter 80
Comment on: Price Discovery in High Resolution 79
Clusters of investors around initial public offering 60
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 45
Cashtag piggybacking: Uncovering spam and bot activity in stock microblogs on twitter 43
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 37
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 36
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 32
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 29
Simulation-driven experimental hypotheses and design: a study of price impact and bubbles 17
Totale 1.125
Categoria #
all - tutte 3.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 3 5 7 7 8 9 10 10 5 10 0
2020/2021105 5 0 5 8 18 26 5 15 6 7 5 5
2021/202283 0 5 13 4 13 7 5 2 10 0 8 16
2022/2023310 8 6 31 20 23 31 11 26 103 2 37 12
2023/2024466 40 43 58 30 43 49 17 5 4 40 27 110
2024/202553 45 8 0 0 0 0 0 0 0 0 0 0
Totale 1.125